25
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Oxidative Status in Chronic Hepatitis C: The Influence of Antiviral Therapy and Prognostic Value of Serum Hydroperoxide Assay

, , , , , , & show all
Pages 573-580 | Received 16 Oct 2003, Published online: 07 Jul 2009

References

  • Poynard, T., Bedossa, P. and Opolon, P. (1997) "Natural history of liver fibrosis progression in patients with chronic hepatitis C", Lancet 349, 825–832.
  • Parola, M. and Rubino, G. (2001) "Oxidative stress-related molecules and liver fibrosis", J. Hepatol. 35, 297–306.
  • Sies, H. (2000) "What is oxidative stress?", In: Keaney, J.F., ed., Oxidative Stress and Vascular Disease (Kluwer Academic Publishers, Boston), pp 1–8.
  • De Maria, N., Colantoni, A., Fagioli, S., Liu, G.J., Rogers, B.K., Farinati, F., et al. (1996) "Association between reactive oxygen species and disease activity in chronic hepatitis C", Free Radic. Biol. Med. 21, 291–295.
  • Shimoda, R., Nagashima, M., Sakamoto, M., Yamaguchi, N., Hirohashi, S., Yokota, J., et al. (1994) "Increased formation of oxidative DNA damage 8-hydroxydeoxyguanosine in human livers with chronic hepatitis", Cancer Res. 54, 3171–3172.
  • Baron, V. and Muriel, P. (1999) "Role of glutathione, lipid permddation and antioxidants on acute bile-duct obstruction in the rat", Biochim. Biophys. Acta 1472, 173–180.
  • Tsai, L.Y., Lee, K.T. and Liu, T.Z. (1998) "Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats", Free Radic. Biol. Med. 24, 732–737.
  • Bianchi, G., Marchesini, G., Fabbri, A., Ronchi, M., Chianese, R. and Grossi, G. (1997) "Lipopermdde plasma levels in patients with liver cirrhosis", Hepatogastroenterology 44, 784–788.
  • Lu, S.C. (1999) "Regulation of glutathione synthesis: current concepts and controversies", FASEB J. 13, 1169–1183.
  • Newsome, P.N., Beldon, I., Moussa, Y., Delahooke, T.E., Poulopoulos, G., Hayes, P.C., et al. (2000) "Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease", Aliment. Pharmacol. Ther. 14, 1295–1301.
  • Peres, W., Turion, M.J., Collado, P.S., Herrmann, S., Marroni, N. and Gonzàlez-Gallego, J. (2000) "The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction", J. Hepatol. 33, 742–750.
  • Larrea, E., Beloqui, 0., Mutioz-Navas, M.A., Civeira, M.P. and Prieto, J. (1998) "Superoxide dismutase in patients with chronic hepatitis C virus infection", Free Radic. Biol. Med. 24, 1235–1241.
  • Loguercio, C., Tuccillo, C., Caporaso, N., Del Vecchio Blanco, G., Morisco, F., Guerriero, C., et al. (1998) "Determi-nation of plasma alpha-glutathione-S-transferases in patients with HCV-related chronic infection: its significance and possible clinical relevance", Liver 18, 166–172.
  • Okuda, M., Li, K., Beard, M.R., Showalter, L.A., Scholle, F., Lemon, S.M., et al. (2002) "Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein", Gastroenterology 22, 366–375.
  • McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., et al. (1998) "IFN alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group", N. Engl. J. Med. 339, 1485–1492.
  • Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., et al. (1998) "IFN alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group", N. Engl. J. Med. 339, 1493–1499.
  • Farinati, F., Cardin, R., De Maria, N., Della Libera, G., Marafin, C., Lecis, E., et al. (1995) "Iron storage, lipid permddation and glutathione turnover in chronic anti-HCV positive hepatitis", J. Hepatol. 22, 449–456.
  • Mutlu-Turkoglu, U., Ademoglu, E., Turkoglu, S., Badur, S., Uysal, M. and Toker, G. (1997) "The effects of interferon-alpha on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis C", Res. Commun. Mol. Pathol. Pharmacol. 96, 357–361.
  • De Franceschi, L., Fattovich, G., Turrini, F., Ayi, K., Brugnara, C., Manzato, E, et al. (2000) "Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage", Hepatology 31, 997–1004.
  • Cesarone, M.R., Belcaro, G., Caratelli, M., Comelli, U., De Sanctis, M.T., Incandela, L., Barsotti, A., Terranova, R. and Nicolaides, A. (1999) "A simple test to monitor oxidative stress", Int. Ang. 18, 127–130.
  • Comelli, U., Terranova, R., Luca, S., Comelli, M. and Alberti, A. (2001) "Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress", J. Nutr. 131, 3208–3211.
  • Verde, V., Fogliano, V., Ritieni, A., Maiani, G., Morisco, F. and Caporaso, N. (2002) "Use of N,N-dimethyl-p-phenylene-diamine to evaluate the oxidative status of human serum", Free Radic. Res. 36, 869–873.
  • Alberti, A., Bolognini, L., Macciantelli, D. and Carratelli, M. (2000) "The radical cation of N,N-diethyl-para-phenilen-diamine: a possible indicator of oxidative stress in biological samples", Res. Chem. Intermed. 26, 253–267.
  • Knodell, R., Ishak, K., Black, W., Chen, T.S., Craig, R., Kaplowits, N., et al. (1981) "Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis", Hepatology 1, 431–435.
  • Lai, M.M. (2002) "Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more", Gastroenterology 122, 568–571.
  • Jain, S.K., Pemberton, P.W., Smith, A., McMahon, R.F.T., Burrows, P.C., Aboutwerat, A., et al. (2002) "Oxidative stress in chronic hepatitis C: not just a feature of late stage disease", J. Hepatol. 36, 805–811.
  • Conjeevaram, H.S., Everhart, J. and Hoofnagle, J.H. (1995) "Predictors of a sustained beneficial response to interferon alpha therapy in chronic hepatitis C", Hepatology 22, 1326–1329.
  • Vendemmiale, G., Grattagliano, I., Portincasa, P., Serviddio, G., Palasciano, G. and Altomare, E. (2001) "Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up", Fur. J. Clin. Investig. 31, 54–63.
  • Loguercio, C., Caporaso, N., Tuccillo, C., Morisco, F., Del Vecchio Blanco, G. and Del Vecchio Blanco, C. (1998) "Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to IFN therapy?", J. Hepatol. 28, 390–395.
  • Sumida, Y., Nakashima, T., Yot, T., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., et al. (2000) "Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection", J. Hepatol. 33, 616–622.
  • Barbaro, G., Di Lorenzo, G., Soldini, M., Parrotto, S., Bellomo, G., Belloni, G., et al. (1996) "Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlation with plasmatic and lymphocytic concentration and with activity of the liver disease", Am. J. Gastroenterol. 91, 2569–2573.
  • Beloqui, 0., Prieto, J., Suarez, M., Gil, B., Qian, C.H., Garcia, N., et al. (1993) "N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study", J. Interferon Res. 13, 279–282.
  • Ideo, G., Bellobuono, A., Tampini, S., Mondazzi, L., Airoldi, A., Benetti, G., et al. (1999) "Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomised, multi-centre study", Fur. J. Gastroenterol. Hepatol. 11, 1203–1207.
  • Look, M.P., Gerard, A., Rao, G.S., Sudhop, T., Fisher, H.P., Sauerbruch, T., et al. (1999) "Interferon / antimddant combi-nation therapy for chronic hepatitis C: a controlled pilot trial", Antiviral Res. 43, 113–122.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.